ChemicalBook >> journal list >> Journal of toxicology. Clinical toxicology >>article

Journal of toxicology. Clinical toxicology

Download PDF

Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement.

Published:1 January 2003 DOI: 10.1081/clt-120018277 PMID: 12645974
Michael I Greenberg, Robert G Hendrickson

Abstract

Intrathecal baclofen is used as a muscle relaxant and antispasmodic in cases of spasticity resulting from central nervous system trauma. The baclofen withdrawal syndrome may include hyperthermia, tachycardia, hypertension, seizures, altered mental status, and psychomotor agitation. We report a case in which the removal of a baclofen pump lead tothe development of severe withdrawal symptoms despite oral baclofen replacement therapy. In order to avoid the development of withdrawal, adequate doses of GABA agonist agents should be administered immediately prior to, and following, baclofen pump removal.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
4-Aminobutyric acid 56-12-2 C4H9NO2 995 suppliers $5.00-$2520.00
Baclofen 1134-47-0 C10H12ClNO2 554 suppliers $11.00-$1250.00

Similar articles

IF:2.5

Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.

Neural Regeneration Research Per Ertzgaard, Claudia Campo,etc Published: 6 March 2017
IF:7.7

Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia.

Neural Regeneration Research G H Fromm, C F Terrence,etc Published: 1 November 1987
IF:0.8

Baclofen intoxication: report of four cases and review of the literature.

Neural Regeneration Research T H Lee, S S Chen,etc Published: 1 February 1992